Anti-SHH/ HHG1/ HLP3 monoclonal antibody

Anti-SHH/ HHG1/ HLP3 antibody for FACS & in-vivo assay

Target products collectionGo to SHH/SHH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T12075-Ab-1/ GM-Tg-hg-T12075-Ab-2Anti-Human SHH monoclonal antibodyHuman
GM-Tg-rg-T12075-Ab-1/ GM-Tg-rg-T12075-Ab-2Anti-Rat SHH monoclonal antibodyRat
GM-Tg-mg-T12075-Ab-1/ GM-Tg-mg-T12075-Ab-2Anti-Mouse SHH monoclonal antibodyMouse
GM-Tg-cynog-T12075-Ab-1/ GM-Tg-cynog-T12075-Ab-2Anti-Cynomolgus/ Rhesus macaque SHH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T12075-Ab-1/ GM-Tg-felg-T12075-Ab-2Anti-Feline SHH monoclonal antibodyFeline
GM-Tg-cang-T12075-Ab-1/ GM-Tg-cang-T12075-Ab-2Anti-Canine SHH monoclonal antibodyCanine
GM-Tg-bovg-T12075-Ab-1/ GM-Tg-bovg-T12075-Ab-2Anti-Bovine SHH monoclonal antibodyBovine
GM-Tg-equg-T12075-Ab-1/ GM-Tg-equg-T12075-Ab-2Anti-Equine SHH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T12075-Ab-1/ GM-Tg-hg-T12075-Ab-2; GM-Tg-rg-T12075-Ab-1/ GM-Tg-rg-T12075-Ab-2;
GM-Tg-mg-T12075-Ab-1/ GM-Tg-mg-T12075-Ab-2; GM-Tg-cynog-T12075-Ab-1/ GM-Tg-cynog-T12075-Ab-2;
GM-Tg-felg-T12075-Ab-1/ GM-Tg-felg-T12075-Ab-2; GM-Tg-cang-T12075-Ab-1/ GM-Tg-cang-T12075-Ab-2;
GM-Tg-bovg-T12075-Ab-1/ GM-Tg-bovg-T12075-Ab-2; GM-Tg-equg-T12075-Ab-1/ GM-Tg-equg-T12075-Ab-2
Products NameAnti-SHH monoclonal antibody
Formatmab
Target NameSHH
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SHH benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SHH/ HHG1/ HLP3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAAV000001human SHH AAV plasmid
    ORF Viral VectorvGMAAV000001human SHH AAV particle


    Target information

    Target IDGM-T12075
    Target NameSHH
    Gene ID6469,20423,29499,716553,608860,111557492,286821,100147450
    Gene Symbol and Synonyms9530036O11Rik,Dsh,HHG1,HLP3,HPE3,Hx,Hxl3,M100081,MCOPCB5,SHH,ShhNC,SMMCI,TPT,TPTPS
    Uniprot AccessionQ15465,Q63673
    Uniprot Entry NameSHH_HUMAN,SHH_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000164690
    Target ClassificationN/A

    The target: SHH, gene name: SHH, also named as HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC, TPT, TPTPS. This gene encodes a protein that is instrumental in patterning the early embryo. It has been implicated as the key inductive signal in patterning of the ventral neural tube, the anterior-posterior limb axis, and the ventral somites. Of three human proteins showing sequence and functional similarity to the sonic hedgehog protein of Drosophila, this protein is the most similar. The protein is made as a precursor that is autocatalytically cleaved; the N-terminal portion is soluble and contains the signalling activity while the C-terminal portion is involved in precursor processing. More importantly, the C-terminal product covalently attaches a cholesterol moiety to the N-terminal product, restricting the N-terminal product to the cell surface and preventing it from freely diffusing throughout the developing embryo. Defects in this protein or in its signalling pathway are a cause of holoprosencephaly (HPE), a disorder in which the developing forebrain fails to correctly separate into right and left hemispheres. HPE is manifested by facial deformities. It is also thought that mutations in this gene or in its signalling pathway may be responsible for VACTERL syndrome, which is characterized by vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, radial and renal dysplasia, cardiac anomalies, and limb abnormalities. Additionally, mutations in a long range enhancer located approximately 1 megabase upstream of this gene disrupt limb patterning and can result in preaxial polydactyly. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.